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Background: Magnesium (Mg) is a necessary element in a vast number of 
enzymatic paths throughout the body, so, its cellular mechanisms affect 
clinical outcome; it is also the main second intracellular cation playing a 
crucial role in ATP/ADP energy conversion. Lack of Mg is usually reported 
in 10% of hospitalized patients worldwide. Chronic hypomagnesaemia is also 
in correlation with many chronic pathologic conditions. The present study 
was designed to assess the correlation of the serum level of Mg in ICU 
admitted patients with their prognosis.  
Materials and Methods: Through a retrospective cross-sectional design, 
180 ICU admitted patients over 18 years, between 2012 and 2014 were 
enrolled in the study; 90 had normomagnesemia and 90 hypomagnesaemia. 
APACHE II score was calculated for patients after 24 hours of admission in 
ICU before measuring serum Mg level of each patient. Then, patients' 
outcomes were assessed. Mortality, hospital stay, requirement for mechanical 
ventilation and duration of mechanical ventilation were recorded.  
Results: Out of total patients with normal serum Mg 22 (22.4%) died while 
36 (40%) died with hypomagnesaemia. There was no significant difference 
between the groups for the length of hospital stay. 48.9% of total patients 
with normal Mg who were admitted in ICU needed ventilator, but 78.9% of 
hypomagnesaemia cases were to use ventilator who were significantly 
higher than the other group. In terms of the time of ventilator use, a 
significant difference was seen between the patients with normal or low 
serum Mg. Individuals with normal Mg needed more days of ventilation, 
interestingly (26.5 vs. 17.5 days).  
Conclusion: Low serum magnesium could be a key factor for assessing 
prognosis among ICU admitted patients, especially in critically ill ones.  
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Introduction 
Magnesium is a necessary element in a vast 
number of enzymatic systems inside the body as well 
as being the main second intracellular cation playing a 
crucial role in ATP/ADP energy conversion (Figure 
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1). The total body magnesium is supposed to be 
around 2000 meq/lit; a half of it available in bones 
while less than 1% in the intracellular solution; 
providing 1.3-2.2 meq/lit plasma concentration and 
20% of it is bind to proteins (1-4). All the body 
organs such as heart, muscles, and kidneys need Mg 
for their good functions. Mg also is crucial for 
managing absorption, metabolism and action of 
several cations like potassium, calcium, cooper and 
zinc. Human needs 300 mg/day of Mg on average, 
which would be raised in pregnancy, breast feeding or 
disease convalescence period (2, 3,5-7). Lack of Mg 
is usually reported in 10% of hospitalized people 
worldwide. Chronic hypomagnesaemia is also in 
correlation with many other chronic medical 
conditions like diabetes mellitus, cardiac disorders, 
osteoporosis, hypertension, and even with higher risk 
of death in the intensive care unit (ICU) admitted 
patients (3, 4). There are many factors, including 
medical conditions like vomiting, diarrhea, and other 
GI problems could disrupt Mg balance in body which 
is, in turn, resulted from viral infections. Also, some 
chronic diseases like irritable bowel syndrome, 
pancreatitis, hyperthyroidism, renal problems, and 
bowel lesions cause chronic hypomagnesaemia 
besides using tea, salt or alcohol, hyperhidrosis, and 
even stress. Hypomagnesaemia represents with 
irritability, anger, sleep problems, nausea and 
vomiting, vertigo, muscular spasms, malaise, 
tachypnea, cardiac arrhythmia and finally seizure. Mg 
is well known as a supplementary treatment in 
diabetes, asthma, fibromyalgia, arrhythmias, 
hypertension, migraine, cardiac diseases, pre-
eclampsia, in addition to restless leg syndrome; it is 
considered as a factor to decrease pain (2, 8-10). 
Hypermagnesemia is also a concern which is 
usually caused by increased renal reabsorption or 
incomplete excretion as well as its much oral intake, 
resulting often in hypotension in individuals (5, 11, 
12). 
The present study was designed to assess the 
correlation of the Mg serum level in ICU admitted 
patients with their prognosis to accept or deny this 
kind of relationship as a prognostic tool. 
Methods 
Through a retrospective cross-sectional design, 
180 ICU admitted patients enrolled the study 
considering inclusion and exclusion criteria. The 
patients were admitted in two university hospitals in 
Southeastern Iran and the center of Sistan and 
Baluchistan province. The records were evaluated 
from 2012 to 2014 which belonged to traumatic cases 
that admitted in ICU and were at least 18 years old. 
Patients who experienced CPR in recent 24 hours in 
addition to cases of burn, recent Mg supplement 
intake, and hospitalization more than 24 hours were 
excluded. The sample size was calculated based on a 
study which defined 55% mortality rate in 
hypomagnesaemia (13) to achieve 80% study power 
















P1 = 55%, P2 = 35%, Z = 1.96, Z   = 0.75 
N= 87  
So, 90 records were defined for each group of 
normomagnesemia and hypomagnesaemia. Normal 
serum Mg was ranged 1.3-2.1 meq/l while 
hypomagnesaemia was defined as Mg<1.3meq/l in 
serum. 
Census sampling was considered through our 
study focusing on the early Mg serum level at the 
point of ICU admission. APACHE II score was 
calculated for patients after 24 hours of admission in 
ICU before recording the Mg serum level of each 
patient in relevant designed questionnaire. There are 
some standard scoring systems to assess the severity 
of the diseases or the risk of death, especially in ICU 
admitted patients among which APACHE II is the 
most popular one (14, 15). The higher the APACHE 
II score, the more the risk of death in patients (15). 
However, patients' outcomes were checked to find 
any correlation in this regard. In addition to mortality; 
hospital stay, requirement to mechanical ventilation 
and its duration were recorded. 
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Statistics 
Using SPSS 20 for windows, all the data were 
analyzed by t-test, Chi-square test and Fisher's exact 
test in order to compare serum Mg levels and their 
means in addition to Pearson's correlation coefficient 
to assess the correlation between serum Mg level and 
the APACHE II score. The confidence interval was 
95% with a 0.05 type1 error and the significance of 
0.05. 
Ethics  
The study design was approved by IRB of 
ethics, coded 617, dated 2012, Research deputy, 
School of Medicine. As a retrospective cross-
sectional study, no intervention was done throughout 
the work; also, all the information was kept as totally 
private and anonymous. 
Results 
Total 180 traumatic patients were admitted in 
ICU of study hospitals in Southeast of Iran with the 
mean age of 42.4±19.6 years, including 102 males 
Table 1: The mean age and sex distribution 
































Figure 1. Magnesium as a key regulator of cellular energetic. 
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(56.7%) and 78 (43.3%) females. Two genders 
significantly differed in terms of mean age (P value 
=0.001). The mean age and sex distribution in two 
groups of normomagnesemia and hypomagnesaemia 
were also significantly different as table 1represents. 
Early serum Mg Level and mortality in ICU  
Out of total patients with normal serum Mg 22 
(22.4%) died while 36 (40%) died with 
hypomagnesaemia (p value =0.035). 
Early serum Mg level and hospital stay 
There was no significant difference between 
the groups in length of hospitalization (p value 
=0.633). The mean lengths of hospitalization were 
24.9 and 23.2 days in normal and high Mg groups, 
respectively. 
Early serum Mg level and ventilator need 
As can be seen in table 2, 48.9% of total 
patients with normal Mg who were admitted in ICU 
needed ventilator, but 78.9% of hypomagnesaemia 
cases were to use ventilator who were significantly 
higher than the other group (p value = 0.001). In 
terms of the time of ventilator use, a significant 
difference was seen between the patients with normal 
or low serum Mg (p value = 0.024). Individuals with 
normal Mg needed more days of ventilation, 
interestingly (26.5 vs. 17.5 days). Table 2 summarizes 
the findings in this matter. 
Discussion 
The findings of the present study show that the 
admitted patients in ICU during our performance who 
experienced low serum Mg levels, not only had 
significantly higher rates of mortality, but also needed 
more ventilator use beside having longer hospital 
stay. There have been a vast number of attempts to 
answer the concerns about the relationship between 
serum levels of Mg and some factors in ICU admitted 
patients such as mortality, hospital stay, ventilator 
needs. For instance, Zafar et al. in 2014 in India 
realized 74.47% mortality in hypomagnesaemia while 
we found 40% mortality rate in similar cases 
compared with normomagnesemia ones (16). Through 
another retrospective performance in 2007, Safavi and 
colleagues showed a much more mortality, hospital 
stay and ICU stay in hypomagnesaemia patients in 
addition to higher rates of electrolyte imbalance like 
total hypocalcemia, hypokalemia, and hyponatremia 
(13). They also found that cases of low serum Mg 
needed more and longer mechanical ventilation 
comparing with other patients. So, monitoring of 
serum Mg may play a prognostic role in ICU which is 
also useful in making early decisions for treatment. 
We found no significantly different hospital stay 
between two groups of normal and low Mg through 
our research work. Mechanical ventilation was 
required in 79% of our patients with 
hypomagnesaemia whilst just less than 50% among 
normomagnesemia cases. 
Table 2: The factors to assess the patients’ prognosis in ICU. 
 
 Normal Mg Low Mg Total Significance 
 24.9 ± 27.4 23.2 ± 18.4 - 0.633 
Yes 44 (48.9%) 71 (78.9%) 115 (63.9%) 0.001 
No 46 (51.1%) 19 (21.1%) 65 (36.1%) 
 26.5 ± 26.9 17.5 ± 15.5 - 0.024 
Alive 68 (75.6%) 54 (60%) 122 (67.8%) 0.035 
Death 22 (24.4%) 36 (40%) 58 (32.2%) 
 90 (50%) 90 (50%) 180 (100%) 
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Limaye in India concluded that diabetes 
mellitus could be a cause of hypomagnesaemia (17). 
Many of attempts showed more needs to ventilation in 
terms of times and duration although we found longer 
ventilation need in normomagnesemia when 
compared with hypomagnesaemia patients. On the 
other hand, Soliman et al. express no correlation 
between Mg serum level and mortality and hospital 
stay (18). They named long ICU stay, diuretics and 
sepsis as the main triggers of hypomagnesaemia. 
Guerin and colleagues not only found no correlation 
between studied factors and serum Mg levels, but also 
blamed hypomagnesaemia as the main cause of low 
prognosis and mortality (10). Either way, low serum 
magnesium sounds to be a key factor to assess the 
prognosis among ICU admitted patients, especially in 
critically ill patients. 
Imperfect record system and laboratory errors 
in serum Mg levels were the most challengeable items 
through the present study. 
Conclusion 
Although there was no significant difference 
between low and normal level Mg groups in term of 
ICU stay, but hypomagnesemia patients had longer 
mechanical ventilation time and mortality rate. So low 
serum magnesium sounds to be a key factor to assess 
the prognosis among ICU admitted patients, 
especially in critically ill patients. 
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